A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 1, Issue 9, 2006, Pages 953-959

  Shafazand, Shirin ^a   Gould, Michael K ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADENOCARCINOMA; AGED; ARTICLE; CALIBRATION; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DECISION MAKING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM METASTASIS; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RISK; THORAX RADIOGRAPHY; TUMOR; AGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MEDIASTINUM TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINAL NEOPLASMS; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34247882833     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200611000-00006     Document Type: Article

References (25)

1. Jassem J, Skokowski J, Dziadziuszko R, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg 2000;119:1141-1146.
2. Suzuki K, Nagai K, Yoshida J, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 1999;118:145-153.
3. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann Thorac Surg 1997;63:1441-1450.
4. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 1998;19:3-13.
5. Backer CL, Shields TW, Lockhart CG, et al. Selective preoperative evaluation for possible N2 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1987;93:337-343.
6. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985;40:556-560.
7. Suzuki K, Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 1999;117:593-598.
8. Silvestri GA, Hoffman B, Reed CE. One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. Chest 2003;123:333-335.
9. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139:879-892.
10. Gould MK, Nease RF Jr, Sox HC Jr, et al. A decision model for mediastinal staging in non-small cell lung cancer. J Gen Intern Med 1997;12(Suppl 1):61.
11. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003;138:724-735.
12. Anonymous. Investigation for mediastinal disease in patients with apparently operable lung cancer. Canadian Lung Oncology Group. Ann Thorac Surg 1995;60:1382-1389.
13. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997;277:488-494.
14. Hosmer DW, Hosmer T, Le Cessie S, et al. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997;16:965-980.
15. Pulkstenis E, Robinson TJ. Two goodness-of-fit tests for logistic regression models with continuous covariates. Stat Med 2002;21:79-93.
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
17. Katz MH. Multivariable Analysis. A Practical Guide for Clinicians. Cambridge: Cambridge University Press, 1999. P. 192.
18. Efron B. The Jackknife, Bootstrap and Other Resampling Plans. Philadelphia: Society for Industrial and Applied Mathematics, 1982.
19. Takamochi K, Nagai K, Suzuki K, et al. Clinical predictors of N2 disease in non-small cell lung cancer. Chest 2000;117:1577-1582.
20. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
21. Kimura H, Iwai N, Ando S, et al. A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers. Ann Thorac Surg 2003;75:1734-1739.
22. Rocha AT, McCormack M, Montana G, et al. Association between lower lobe location and upstaging for early-stage non-small cell lung cancer. Chest 2004;125:1424-1430.
23. Sox HJ, Blatt MA, Higgins MC, et al. Medical Decision Making. Boston: Butterworth-Heinemann, 1988.
24. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-855.
25. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology 1999;213:530-536.